Now known as Point Therpeutics, HemaSure develops, manufactures and markets proprietary filtration systems that increase the safety of donated blood and improve blood transfusion and collection procedures. The Company1s products on the market include the LeukoNet Filter, which removes potentially harmful leukocytes from donated blood, and the LeukoVir* Filter, designed to remove viral inactivation chemicals. The overall goal of HemaSure is to make blood safer by preventing the transfusion of harmful agents in donated blood.
